Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-11

Clinical Trial Update: Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults. [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and immunogenicity of RTS,S/AS02A and RTS,S/AS01B malaria vaccines in malaria-experienced adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RTS,S/AS01B (RTS,S/AS01B)
  • RTS,S/AS02A (RTS,S malaria vaccine with AS02A adjuvant)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Plasmodium Falciparum | Phase 2 | Status: COMPLETED | Results posted: 2020-12-11